A Patient-Directed Mobile Tool to Streamline the QoL Assessment and Monitoring in Urothelial Carcinoma
NCT06982794 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2025-05-21
Summary
The goal of this observational study is to select contents and tools for the future development of a web app aiming to support patients' navigation for empowering decision-making through a higher awareness of urothelial carcinoma and its treatments, improving also educational aspects.
The main question it aims to answer is:
What are the contents that patients diagnosed with urothelial carcinoma find useful to include in a web app to streamline their quality of life assessment and monitoring?
Participants candidate for systemic treatments, or already under treatment, will answer questionnaires about the tools to include in a web app designed for urothelial carcinoma.
Conditions
- Urothelial Carcinoma (UC)
Sponsors & Collaborators
-
IRCCS San Raffaele
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-06-30
- Primary Completion
- 2025-09-30
- Completion
- 2025-10-31
Countries
- Italy
Study Locations
More Related Trials
-
Neoadjuvant Nivolumab for Upper Tract Urothelial Carcinoma
NCT05160285 ·Status: UNKNOWN ·Phase: PHASE2
-
Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue
NCT02379429 ·Status: RECRUITING
-
Feasibility of Neo-adjuvant Versus Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma
NCT02969083 ·Status: RECRUITING ·Phase: PHASE2
-
Neoadjuvant PD-1 Monoclonal Antibody Plus Cisplatin-based Chemotherapy in Locally Advanced Upper Tract Urothelial Carcinoma
NCT04672317 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluation of Clinical Outcomes, Tolerability, and Costs of Avelumab Maintenance and Pembrolizumab Second-Line Therapy in Advanced Urothelial Cancer.
NCT07207928 ·Status: COMPLETED
-
A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)
NCT05562830 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Criteria for Selecting First-line Metastatic Treatment for Patients With Urothelial Carcinoma
NCT07339878 ·Status: RECRUITING
-
CLE Characteristics of Upper Urinary Tract Urothelial Carcinoma
NCT03013920 ·Status: COMPLETED
-
Registry Platform Urologic Cancer
NCT03374267 ·Status: RECRUITING
-
Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study
NCT06350734 ·Status: ACTIVE_NOT_RECRUITING
-
Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Nephroureterectomy for Primary Upper Tract Urothelial Carcinoma Patients
NCT02923557 ·Status: UNKNOWN ·Phase: PHASE2
-
Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder Cancer
NCT07095751 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Safety & Efficacy of Durvalumab+Neoadjuvant Chemotherapy for High-risk Urothelial Carcinoma of the Upper Urinary Tract
NCT04617756 ·Status: RECRUITING ·Phase: PHASE2
-
An Education and Navigation Support Tool to Improve Participation in Care Coordination Among Patients With Locally Advanced, Metastatic and Unresectable Bladder Cancer and Their Caregivers
NCT06414317 ·Status: RECRUITING ·Phase: NA
-
To Detect the Sensitivity of the UroMark Assay
NCT02781428 ·Status: COMPLETED
-
Bio Clinical Collection of Urothelial Carcinoma
NCT04970472 ·Status: RECRUITING
-
Diagnostic Relevance of Laser Confocal Microscopy for the Screening of Upper Urinary Tract Tumors
NCT02276924 ·Status: COMPLETED ·Phase: NA
-
Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the Bladder
NCT02968732 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 1)
NCT02951767 ·Status: COMPLETED ·Phase: PHASE2
-
Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Diagnostic Ureteroscopy for Primary Upper Tract Urothelial Carcinoma Patients
NCT02740426 ·Status: UNKNOWN ·Phase: PHASE2
-
POST URS Chemotherapy Instillation
NCT06167057 ·Status: RECRUITING ·Phase: NA
-
Personalized Urine Biomarker for Patients With Bladder Cancer
NCT05467267 ·Status: UNKNOWN
-
Liquid Biospy for Urinary Cancers
NCT06116396 ·Status: RECRUITING
-
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
NCT05874921 ·Status: RECRUITING
-
Immunohistochemical Expression of CXCL5 as a Valuable Prognostic Marker in Urinary Bladder Urothelial Carcinoma
NCT05139134 ·Status: UNKNOWN